Waltz Health is on a mission to lower drug costs for patients and payers alike. The company was founded by former PBM executive Mark Theiler, who has intimate knowledge of the inner workings of the pharmaceutical pricing system. And he’s not alone – the Waltz team includes experienced tech professionals who are using their skills to develop innovative solutions to the problem of high drug prices.
So far, Waltz has had success in negotiating lower prices for drugs from major pharmaceutical companies. And they’re not stopping there – they’re continuing to work on new ways to bring down the cost of prescription drugs for everyone involved.
Why waltz health is necessary for drugs people?
Waltz Health is a new company that was founded with the goal of lowering drug costs for patients and payers alike. Led by former PBM executive Mark Thierer, who has extensive knowledge of the pharmaceutical pricing system, Waltz brings together a team of experienced tech professionals to develop innovative solutions to the problem of high drug prices.
With its focus on driving down drug costs, Waltz has already had success in negotiating lower prices from major pharmaceutical companies. And it shows no signs of stopping – the company continues to explore new ways to make prescription drugs more affordable for everyone involved. Whether through technology-driven solutions or by leveraging insider knowledge and industry expertise, Waltz is committed to improving access to essential medications for all.
Benefits of waltz health:
- Waltz Health is committed to lowering drug costs for patients and payers alike.
- With insider knowledge of the pharmaceutical pricing system, Waltz is able to negotiate better prices for drugs from major pharmaceutical companies.
- Thanks to their innovative technology solutions, Waltz is constantly looking for new ways to lower drug costs and improve access to affordable medications.
- By partnering with Waltz Health, patients and payers can be confident that they are getting the best possible deal on their prescription medications. And that’s good news for everyone.
Cardiovascular Benefit OF Statins in Patients Aged 75 Years or Older
Although the use of statins has been shown to reduce the risk of cardiovascular disease (CVD) in patients 75 years of age or older, their actual effect on hard clinical outcomes in this population is unknown. One large, prospective observational study followed 4,686 patients aged 75 years or older for a mean of 3.9 years and found that statin users had a significantly lower risk of all-cause mortality, CVD mortality, myocardial infarction (MI), and stroke compared with nonusers. However, the absolute risk reductions were small (between 1% and 2%), and most of the benefit was seen in patients with pre-existing CVD.
